{"id":"CHEMBL1071","canonicalSmiles":"O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1","inchiKey":"OFPXSFXSNFPTHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXAPROZIN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daypro","Oxaprozin"],"synonyms":["NSC-310839","Oxaprozin","WY-21,743","WY-21743"],"crossReferences":{"DailyMed":["oxaprozin"],"PubChem":["11110656","11110657","144203610","170464987","26719634","26747622","4254158","455291","50106813","50106814","85230870","90340983"],"Wikipedia":["Oxaprozin"],"drugbank":["DB00991"],"chEBI":["7822"]},"childChemblIds":["CHEMBL1200463"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0005178","EFO_0005755","EFO_0002609"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 4 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1075834","canonicalSmiles":"C#CCOc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC","inchiKey":"UIWZIDIJCUEOMT-PKNBQFBNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SHP-627","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FT-011","FT-11","Ft011","Shp-627"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1083390","canonicalSmiles":"O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1","inchiKey":"JJZFWROHYSMCMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INTEPIRDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-742457","GSK742457","Intepirdine","RVT-101","SB-742457","Sb-742457"],"crossReferences":{"Wikipedia":["SB-742,457"],"drugbank":["DB12680"]},"linkedTargets":{"rows":["ENSG00000158748"],"count":1},"linkedDiseases":{"rows":["HP_0000726","MONDO_0004975"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL113948","canonicalSmiles":"CCCC[C@@H](C=O)NC(=O)O[C@H](Cc1ccccc1)C(C)C","inchiKey":"ZLZXUNHJWVLGTE-DLBZAZTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL113948","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07592"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL118218","canonicalSmiles":"CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1","inchiKey":"NICJCIQSJJKZAH-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IROFULVEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(hydroxymethyl)acylfulvene","6-hydroxymethylacylfulvene","Irofulven","LP-100","MGI 114","MGI-114","NSC-683863"],"crossReferences":{"PubChem":["520035"],"Wikipedia":["Irofulven"],"drugbank":["DB05786"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 19 investigational indications."}
{"id":"CHEMBL1187231","canonicalSmiles":"C/N=C(\\N)N(C)C(=N)N","inchiKey":"LJVNRPAERZRHDF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METFORMIN XR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL494397"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL119521","canonicalSmiles":"CCCCCCP(=O)(O)OCC","inchiKey":"XPLOQMVUXWZLET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYL HYDROGEN HEXYLPHOSPHONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexyl-Phosphonic Acid Monoethyl Ester"],"crossReferences":{"drugbank":["DB04321"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1198650","canonicalSmiles":"N=C(N)c1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CCC2CCCC2)cc1","inchiKey":"BNCHHUFGEOJCNH-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198650","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07095"]},"childChemblIds":["CHEMBL609619"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200622","canonicalSmiles":"C[C@@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C)C(C)(C)O","inchiKey":"BPKAHTKRCLCHEA-UBFJEZKGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARICALCITOL","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paricalcitol","Zemplar"],"synonyms":["COMPOUND 49510","COMPOUND-49510","Paricalcitol"],"crossReferences":{"DailyMed":["paricalcitol"],"PubChem":["144206540"],"Wikipedia":["Paricalcitol"],"drugbank":["DB00910"],"chEBI":["7931"]},"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0003086","HP_0002901","EFO_1001173","EFO_0000616","HP_0000093","EFO_0000401","MONDO_0007254","EFO_1000657","EFO_0004194","EFO_1002048","MONDO_0008315","EFO_0005754","EFO_0003896","EFO_1000044","EFO_0008506","EFO_0002517","EFO_0003884","EFO_0004272","EFO_0001378","EFO_0004285","MONDO_0005148","MONDO_0024880"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 3 approved and 16 investigational indications."}
{"id":"CHEMBL1200679","canonicalSmiles":"[Cl-].[Cl-].[Zn+2]","inchiKey":"JIAARYAFYJHUJI-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ZINC CHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-529648","Zinc chloride","Zincum muriaticum"],"crossReferences":{"DrugCentral":["4344"],"PubChem":["144211809"],"Wikipedia":["Zinc_chloride"],"drugbank":["DB14533"],"chEBI":["49976"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986."}
{"id":"CHEMBL1200922","canonicalSmiles":"CCC(C)C(C)(COC(N)=O)COC(N)=O","inchiKey":"LEROTMJVBFSIMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBUTAMATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dormate"],"synonyms":["Axiten","Butatensin","Carbuten","Dicamoylmethane","Encapla","Ipotensivo","Mebutamat","Mebutamate","Mebutina","Mioartrina","NSC-163921","Prean","Preminex","Sigmafon","Vallene","W-583"],"crossReferences":{"PubChem":["170465233"],"Wikipedia":["Mebutamate"],"drugbank":["DB06797"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for anxiety."}
{"id":"CHEMBL1201170","canonicalSmiles":"O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+]","inchiKey":"WJSIUCDMWSDDCE-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":true,"name":"LITHIUM CITRATE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lithium citrate"],"crossReferences":{"Wikipedia":["Lithium_citrate"],"drugbank":["DB14507"],"chEBI":["64735"]},"childChemblIds":["CHEMBL2103738"],"linkedTargets":{"rows":["ENSG00000082701","ENSG00000105723","ENSG00000133731"],"count":3},"linkedDiseases":{"rows":["EFO_0009963","EFO_0005407"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1980 and is indicated for psychosis and bipolar i disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201484","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM POLYSTYRENE SULFONATE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kalexate","Kayexalate","Kionex","Resonium a","Sodium polystyrene sulfonate"],"synonyms":["Amberlite forte ir 120","Amberlite ir 120","Amberlite ir-120","Amberlite ir120 h","Amberlite irp-69","Amberlite irp-69m","Amberlite irp69","Ir 120","Polistirex acid","Polystyrene Sulfonate","Polystyrene sulfonate","Polystyrene sulfonic acid","Polystyrene sulphonate","Sodium polistirex","Sodium polystyrene sulfonate","Sodium polystyrene sulphonate"],"crossReferences":{"DailyMed":["sodium%20polystyrene%20sulfonate"],"DrugCentral":["4487"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1958 and is indicated for hyperkalemia and has 1 investigational indication."}
{"id":"CHEMBL1201716","drugType":"Protein","blackBoxWarning":false,"name":"MECASERMIN","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Increlex","Myotrophin"],"synonyms":["CEP-151","Cg-gf2","Cg-igf-1","Insulin-like growth factor 1","Insulin-like growth factor i","Mecasermin","Mecasermin recombinant","Mechano growth factor","Pv-802","Pv802","Rh-oligopeptide-2","Sh-oligopeptide-2","Somatomedin c","Somatomedin c, human","Vexxon-igf-1"],"crossReferences":{"DailyMed":["mecasermin%20recombinant"],"DrugCentral":["5009"],"Wikipedia":["Mecasermin"]},"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["Orphanet_48652","Orphanet_648","HP_0001507","MONDO_0002177","EFO_0004260","Orphanet_778","EFO_0000384","Orphanet_181393","GO_0007568","HP_0004322","MONDO_0005301","EFO_1001348","MONDO_0004976","HP_0001510","EFO_0000400","EFO_1001434","EFO_0004215","EFO_0004705","EFO_1001158"],"count":19},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and is indicated for hypothyroidism and growth delay and has 14 investigational indications."}
{"id":"CHEMBL1206161","canonicalSmiles":"O=C(O)[C@H]1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1","inchiKey":"XDKRVNKVAKCFGW-WXWBBQJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1206161","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15099"]},"childChemblIds":["CHEMBL232357"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213271","canonicalSmiles":"Cn1c(N)nc2ncc(-c3ccccc3)cc21","inchiKey":"UQVKZNNCIHJZLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-AMINO-1-METHYL-6- PHENYLIMIDAZO[4,5- B]PYRIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine"],"drugbank":["DB08398"],"chEBI":["76290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233953","canonicalSmiles":"OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)N/C(=N/O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"AHRWQUNEPBVNOT-IVJVVCOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233953","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01922"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234613","canonicalSmiles":"NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1","inchiKey":"BAWFJGJZGIEFAR-NNYOXOHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NADIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".beta.-nad","CO-I","Codehydrogenase","Codehydrogenase i","Coenzyme i","Cozymase","DPN","Diphosphopyridine nucleotide","NAD","NAD+","NSC-20272","Nadide","Nadidum","Nicotinamide Adinine Dinucleotide","Nicotinamide adenine dinucleotide"],"crossReferences":{"PubChem":["144203872"],"drugbank":["DB14128"],"chEBI":["44215"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236157","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)O2)c(=O)[nH]c1=O","inchiKey":"JCFDSPQTEMXXLO-SLFMBYJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236157","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03280"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236189","canonicalSmiles":"O[As](O)O","inchiKey":"GCPXMJHSNVMWNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIHYDROXYARSENITE(III)","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04456"],"chEBI":["49900"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1262","canonicalSmiles":"Clc1ccc(CO/N=C(\\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1","inchiKey":"QRJJEGAJXVEBNE-HKOYGPOVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXICONAZOLE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Oxiconazole","Oxistat","Oxizole"],"crossReferences":{"DailyMed":["oxiconazole%20nitrate"],"Wikipedia":["Oxiconazole"],"drugbank":["DB00239"],"chEBI":["7825"]},"childChemblIds":["CHEMBL1200836"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1988 and is indicated for tinea and tinea pedis."}
{"id":"CHEMBL134022","canonicalSmiles":"COc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)c1","inchiKey":"NVVWVYYHTKCIAE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL134022","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04010"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1397","canonicalSmiles":"CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O","inchiKey":"RAGOYPUPXAKGKH-XAKZXMRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POSACONAZOLE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Noxafil","Noxafil powdermix kit"],"synonyms":["Noxafil","Posaconazole","SCH 56592","SCH-56592"],"crossReferences":{"DailyMed":["posaconazole"],"Wikipedia":["Posaconazole"],"drugbank":["DB01263"],"chEBI":["64355"]},"childChemblIds":["CHEMBL4303216","CHEMBL1908108"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 3 approved and 10 investigational indications."}
{"id":"CHEMBL14193","canonicalSmiles":"O=Cc1ccc(O)cc1","inchiKey":"RGHHSNMVTDWUBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-HYDROXYBENZALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Para-Hydroxybenzaldehyde","p-hydroxybenzaldehyde"],"crossReferences":{"PubChem":["124899140"],"Wikipedia":["4-Hydroxybenzaldehyde"],"drugbank":["DB03560"],"chEBI":["17597"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL147806","canonicalSmiles":"CC(C)(C)NCc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O","inchiKey":"ZVMMVSSEAMUNGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-369796","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BDBM50134936","CHEMBL147806","GSK 369796","GSK369796","Gsk-369796","Gsk369796","N-tert-butyl isoquine","N-tert-butylisoquine","Ntbisq","ZINC1912685"],"childChemblIds":["CHEMBL515899"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1505","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12","inchiKey":"WKEMJKQOLOHJLZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALMOTRIPTAN","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Almotriptan","LAS 31416","LAS-31416","NSC-760092"],"crossReferences":{"DailyMed":["almotriptan%20malate"],"PubChem":["170465288","174006290","26748976"],"Wikipedia":["Almotriptan"],"drugbank":["DB00918"],"chEBI":["520985"]},"childChemblIds":["CHEMBL1200521"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546","ENSG00000179097"],"count":3},"linkedDiseases":{"rows":["MONDO_0005277","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for migraine disorder."}
{"id":"CHEMBL1579","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"MKPDWECBUAZOHP-AFYJWTTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARAMETHASONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Paramethasone"],"crossReferences":{"Wikipedia":["Paramethasone"],"drugbank":["DB01384"],"chEBI":["7922"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL161084","canonicalSmiles":"O=C(c1ccco1)N(c1cnccn1)C1CCN(CCc2ccccc2)CC1","inchiKey":"BJZZDOLVVLWFHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRFENTANIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A 3508","Mirfentanil","OHM 10579"],"crossReferences":{"drugbank":["DB09175"]},"childChemblIds":["CHEMBL2448139"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL163","canonicalSmiles":"CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1","inchiKey":"NCDNCNXCDXHOMX-XGKFQTDJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"RITONAVIR","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Norvir","Ritonavir"],"synonyms":["A-84538","ABBOTT-84538","ABT-538","Empetus","NSC-693184","Norvir","Ritomune","Ritonavir","Ritonavir related compounds mixture","Ritonavirum","Ritovir","Viekirax","Viriton"],"crossReferences":{"DailyMed":["ritonavir"],"PubChem":["144206522","144206981","170464891","26719904","29215414"],"Wikipedia":["Ritonavir"],"drugbank":["DB00503"],"chEBI":["45409"]},"linkedTargets":{"rows":["ENSG00000160870","ENSG00000106258","ENSG00000160868","ENSG00000021461"],"count":4},"linkedDiseases":{"rows":["EFO_0007386","EFO_0003086","EFO_0001361","EFO_0000558","EFO_0004234","EFO_1000637","EFO_0007304","EFO_0002950","MONDO_0100116","EFO_0000544","EFO_0007224","EFO_1001348","EFO_0003047","MONDO_0004976","EFO_0000694","EFO_0000765","EFO_0000180","Orphanet_3389","EFO_0004197","EFO_0000537","EFO_0000311","EFO_0009708","EFO_0003106","EFO_0004220","MONDO_0100096","EFO_0001068","EFO_0002614","EFO_0000764","EFO_0001421","EFO_0007328","EFO_0000763","EFO_0000691","EFO_0000519","EFO_0009878"],"count":34},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 5 approved and 24 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1673159","canonicalSmiles":"CC1CCC(C(=O)N(c2cc(-c3ccccc3)sc2C(=O)[O-])C2CCC(O)CC2)CC1.[Na+]","inchiKey":"SSERCMQZZYTNBY-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"VCH-759","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1741078","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VCH-759","Vch-759"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1713","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21.Cl","inchiKey":"FBSMERQALIEGJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORPROMAZINE HYDROCHLORIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL71","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chloractil","Chlorazine","Chlorpromazine hydrochloride","Chlorpromazine hydrochloride intensol","Largactil","Largactil fte","Promapar","Rimazine","Sonazine","Thorazine"],"synonyms":["Chlorpromazine HCl","Chlorpromazine hcl","Chlorpromazine hydrochloride","Chlorpromazini hydrochloridum","Klorproman","Marazine","NSC-17479","Nci-c05210","Norcozine"],"crossReferences":{"DailyMed":["chlorpromazine%20hydrochloride"],"PubChem":["144210835","14743551","26751622","50106001","50125717","56422870","855926"],"chEBI":["3649"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1741037","canonicalSmiles":"C[C@@H](Oc1ccc(Oc2cnc3ccc(Cl)cc3n2)cc1)C(=O)O","inchiKey":"NUQZXROIVGBRGR-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R(+)XK469","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R(+)xk469"],"crossReferences":{"PubChem":["525927"]},"childChemblIds":["CHEMBL1433897"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1750","canonicalSmiles":"Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F","inchiKey":"WDDPHFBMKLOVOX-AYQXTPAHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFARABINE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clolar","Evoltra"],"synonyms":["Clofarabine","Clolar","NSC-759857"],"crossReferences":{"DailyMed":["clofarabine"],"PubChem":["144205735","170465145"],"Wikipedia":["Clofarabine"],"drugbank":["DB00631"],"chEBI":["681569"]},"linkedTargets":{"rows":["ENSG00000177084","ENSG00000101868","ENSG00000146143","ENSG00000062822","ENSG00000148229","ENSG00000167325","ENSG00000198056","ENSG00000100479","ENSG00000077514","ENSG00000106628","ENSG00000014138","ENSG00000175482"],"count":12},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","MONDO_0013730","MONDO_0000873","EFO_1001779","EFO_0005803","EFO_0000220","MONDO_0019457","EFO_0000222","EFO_0005952","MONDO_0003541","EFO_0000224","EFO_0000311","EFO_0000565","EFO_1000318","MONDO_0015760","EFO_0000339","EFO_0000096","EFO_0000095","EFO_0000574","Orphanet_2781","MONDO_0020743","EFO_0000183","EFO_0001378"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and has 4 approved and 17 investigational indications."}
{"id":"CHEMBL1779046","canonicalSmiles":"O=C(O[C@H]1CN2CCC1CC2)N(Cc1cc(F)c(F)c(F)c1)c1cccc(F)c1","inchiKey":"UXZDMXYRRQJIBJ-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARAFENACIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Svt-40776","Tarafenacin"],"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_1000781"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1812161","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O","inchiKey":"LNOVHERIIMJMDG-XZXLULOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VATIQUINONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-Alpha-Tocotrienol Quinone",".alpha.-tocotrienol quinone","Alpha tocotrienol quinone","Alpha-tocotrienol quinone","EPI-743","Vatiquinone"],"crossReferences":{"drugbank":["DB11917"]},"linkedTargets":{"rows":["ENSG00000181019"],"count":1},"linkedDiseases":{"rows":["Orphanet_68380","EFO_0003756","Orphanet_506","EFO_1001254","EFO_0004145","EFO_0004895","MONDO_0005180","Orphanet_778","Orphanet_699","Orphanet_95"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL191413","canonicalSmiles":"CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1","inchiKey":"KQDRVXQXKZXMHP-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPARIXIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DF 1681Y","DF-1681Y","DF1681Y","Df-1681y","Reparixin","Repertaxin"],"crossReferences":{"PubChem":["144205825"],"drugbank":["DB12614"]},"childChemblIds":["CHEMBL1527147"],"linkedTargets":{"rows":["ENSG00000180871","ENSG00000163464"],"count":2},"linkedDiseases":{"rows":["EFO_0003106","MONDO_0100096","EFO_0002687","MONDO_0005147","MONDO_0007254","EFO_0007541","EFO_0000342"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2097002","canonicalSmiles":"O=[Se](=O)(O)O","inchiKey":"QYHFIVBSNOWOCQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELENIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11068"],"chEBI":["18170"]},"childChemblIds":["CHEMBL114503"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103975","canonicalSmiles":"CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(N)=O)NC1=O","inchiKey":"SWXOGPJRIDTIRL-KTJGOPLGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VAPREOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sanvar"],"synonyms":["BMY-41606","Bmy-41606","DP-05-094","RC-160","Vapreotide","Vapreotide acetate"],"childChemblIds":["CHEMBL2218872"],"linkedTargets":{"rows":["ENSG00000162009","ENSG00000278195","ENSG00000180616"],"count":3},"linkedDiseases":{"rows":["MP_0001914","EFO_0005323","EFO_0009545","EFO_0000666"],"count":4},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104095","canonicalSmiles":"C[N+](C)(C)CCO.O=C([O-])c1ccccc1O","inchiKey":"UDKCHVLMFQVBAA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLINE SALICYLATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arthropan","Dinnefords"],"synonyms":["Choline salicylate","Choline salicylic acid salt","Choline subsalicylate","Choline, salicylate (salt)","Salicylic acid choline salt","Salicylic acid, ion(1-), choline"],"crossReferences":{"drugbank":["DB14006"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and fever."}
{"id":"CHEMBL2104807","canonicalSmiles":"CCCCc1cc2c(=O)c(C(=O)OC)c[nH]c2cc1OCc1ccccc1","inchiKey":"NNOPDLNHPOLRRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEQUINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AY-20,385","AY-20385","ICI 55,052","ICI-55052","Methyl benzoquate","Neoquate","Nequinate"],"crossReferences":{"PubChem":["144206498"],"drugbank":["DB11433"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105107","canonicalSmiles":"C[C@H](CC#CC(C)(C)O)[C@H]1CC[C@@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C","inchiKey":"HHGRMHMXKPQNGF-WNSNRMDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INECALCITOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Inecalcitol","TX-522","Tx-522"],"crossReferences":{"drugbank":["DB04796"]},"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0000339","EFO_0000222"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105372","canonicalSmiles":"CCN(CC)CC(C)OC(=O)C1CCCCC1(O)C1CCCCC1","inchiKey":"XPYLKZZOBVLVHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROCIVERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LG-30158","Rilaten","Rociverine"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107608","canonicalSmiles":"Cn1c(=O)c2c(ncn2CCNCC(O)c2ccc(O)c(O)c2)n(C)c1=O","inchiKey":"WMCMJIGLYZDKRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THEODRENALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Noradrenaline theophylline","Theodrenaline"],"crossReferences":{"drugbank":["DB12927"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107763","canonicalSmiles":"Cc1cc(=O)oc2cc(O[C@@H]3SC[C@@H](O)[C@H](O)[C@H]3O)ccc12","inchiKey":"JRHNIQQUVJOPQC-AQNFWKISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ODIPARCIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Odiparcil"],"crossReferences":{"PubChem":["170466179"],"drugbank":["DB06609"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108187","drugType":"Antibody","blackBoxWarning":false,"name":"CLENOLIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CE9?4PE","Clenoliximab","IDEC-151"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108693","drugType":"Unknown","blackBoxWarning":false,"name":"SYRUP","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Simple syrup","Syrup"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2109637","drugType":"Antibody","blackBoxWarning":false,"name":"HUHMFG1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-1402","AS1402","HUHMFG1","Huhmfg1","MOAB HuHMFG1","R1550","Therex","humanized IgG1 monoclonal antibody","humanized human milk fat globule-1 monoclonal antibody"],"linkedTargets":{"rows":["ENSG00000185499"],"count":1},"linkedDiseases":{"rows":["MONDO_0008170","MONDO_0007254","MONDO_0002087","EFO_0000305"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL220808","canonicalSmiles":"Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1","inchiKey":"HKFMQJUJWSFOLY-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARIZOTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD-77697","Sarizotan"],"crossReferences":{"drugbank":["DB06454"]},"childChemblIds":["CHEMBL2146110"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["EFO_0004280","MONDO_0005180","Orphanet_778"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL225546","canonicalSmiles":"C[C@]12CCc3c(ccc4cc(O)ccc34)[C@@H]1CCC2=O","inchiKey":"PDRGHUMCVRDZLQ-WMZOPIPTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EQUILENIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Equilenin"],"crossReferences":{"Wikipedia":["Equilenin"],"drugbank":["DB03515"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL233970","canonicalSmiles":"N=C1NC(=O)/C(=C/c2ccc(-c3ccc(S(N)(=O)=O)c(C(F)(F)F)c3)o2)S1","inchiKey":"RGVVHQNJKUNSFQ-WDZFZDKYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL233970","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07538"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364659","drugType":"Antibody","blackBoxWarning":false,"name":"ONTUXIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MORAB-004","Ontecizumab","Ontuxizumab"],"linkedTargets":{"rows":["ENSG00000174807"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001968","EFO_0002617"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2365940","canonicalSmiles":"C[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](CC(C#N)(c1ccccc1)c1ccccc1)C2","inchiKey":"BKLAJZNVMHLXAP-AGYIDARRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAROTROPIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Darotropium cation","Darotropium ion"],"childChemblIds":["CHEMBL2308782"],"linkedTargets":{"rows":["ENSG00000180720","ENSG00000184984","ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":5},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL237370","canonicalSmiles":"O=C(/C=C/c1ccc(Cl)cc1Cl)NO","inchiKey":"LHTLDFWBUPYUDR-DUXPYHPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINNAMIC ACID HYDROXAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,4-Dichlorocinnamic Hydroxamate","2,4-Dichlorocinnamic Hydroxamic Acid","2,4-Dichlorocinnamichydroxamic Acid","2,4-Dichlorocinnamyl Hydroxamic Acid","Cinnamic Acid Hydroxamate"],"crossReferences":{"drugbank":["DB07818"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267099","canonicalSmiles":"Nc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"HDZZVAMISRMYHH-KCGFPETGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUBERCIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tubercidin"],"crossReferences":{"PubChem":["26757019","47193881"],"drugbank":["DB03172"],"chEBI":["48267"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL270164","canonicalSmiles":"Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1","inchiKey":"PMMLSQFPBFKLHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW607117X","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW607117X"],"crossReferences":{"PubChem":["124349856"],"drugbank":["DB07833"],"chEBI":["49627"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275084","canonicalSmiles":"CC(C)Cn1c(=O)n(C)c(=O)c2nc[nH]c21","inchiKey":"APIXJSLKIYYUKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOBUTYLMETHYLXANTHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Acetoxy-Benzoic Acid","3-Isobutyl-Methylxanthine"],"crossReferences":{"PubChem":["11111325","26732612","26747540","26747541","50106451","90340936"],"Wikipedia":["IBMX"],"drugbank":["DB07954"],"chEBI":["34795"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL279816","canonicalSmiles":"ClC=C(Cl)Cl","inchiKey":"XSTXAVWGXDQKEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICHLOROETHYLENE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorylen","Trilene"],"synonyms":["Anamenth","Densinfluat","Germalgene","Narkosoid","Trichloroethene","Trichloroethylene","Westrosol"],"crossReferences":{"PubChem":["144204652","144209741","17389697","26752936"],"Wikipedia":["Trichloroethylene"],"drugbank":["DB13323"],"chEBI":["16602"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL285527","canonicalSmiles":"O=S(=O)(O)c1cccc2cccc(Nc3ccccc3)c12","inchiKey":"FWEOQOXTVHGIFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL285527","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124896729","47193709"],"Wikipedia":["8-Anilinonaphthalene-1-sulfonic_acid"],"drugbank":["DB04474"],"chEBI":["39708"]},"childChemblIds":["CHEMBL1530925"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL286494","canonicalSmiles":"Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65","inchiKey":"BTXNYTINYBABQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYPERICIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hipericin","Hypericin","Hypericum red","NSC-407313","SGX301"],"crossReferences":{"PubChem":["124892429","26755796","26756738","579322","580981"],"Wikipedia":["Hypericin"],"drugbank":["DB13014"],"chEBI":["5835"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL291962","canonicalSmiles":"CC(C)C[C@H](N)C(=O)O","inchiKey":"ROHFNLRQFUQHCH-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEUCINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E641","FEMA NO. 3297","L-leucine","Leucine","Leucine, l","NSC-46709"],"crossReferences":{"PubChem":["4253012"],"Wikipedia":["Leucine"],"drugbank":["DB00149"],"chEBI":["15603"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3039597","canonicalSmiles":"CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O","inchiKey":"NPEFREDMMVQEPL-RWPARATISA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GENTAMICIN","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Gentamicin","Gentamycin","Lyramycin","Oksitselanim","SCH-9724","Septigen","Uromycine"],"crossReferences":{"DailyMed":["gentamicin%20sulfate"],"DrugCentral":["4265"]},"childChemblIds":["CHEMBL3039594"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and has 8 approved and 30 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL306823","canonicalSmiles":"O=C([O-])C(Cl)Cl.[Na+]","inchiKey":"LUPNKHXLFSSUGS-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM DICHLOROACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceresine"],"synonyms":["CMI X-11S","CPC-211","DCA","Dca sodium","NSC-744479","Sodium dichloroacetate"],"crossReferences":{"PubChem":["144207122","144211711","50112986"]},"linkedTargets":{"rows":["ENSG00000067992","ENSG00000004799","ENSG00000152256","ENSG00000005882"],"count":4},"linkedDiseases":{"rows":["EFO_0003777","EFO_0001361","Orphanet_765","EFO_1000036","EFO_0000181","EFO_0000519"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL308148","canonicalSmiles":"CC(=O)NC1(c2ccccc2)CCN(CC[C@H](CN(C)C(=O)c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1","inchiKey":"PGKXDIMONUAMFR-AREMUKBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAREDUTANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Saredutant","Sr-48968"],"crossReferences":{"Wikipedia":["Saredutant"],"drugbank":["DB06660"]},"linkedTargets":{"rows":["ENSG00000075073"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","MONDO_0002009","EFO_0005230"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL31422","canonicalSmiles":"Cc1occc(=O)c1O","inchiKey":"XPCTZQVDEJYUGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MALTOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-methylpyromeconic acid","E-636","E636","FEMA NO. 2656","Ins no.636","Ins-636","Larixic acid","Maltol","NSC-2829","NSC-404458","Palatone","Veltol"],"crossReferences":{"PubChem":["11532903","144209413","144210438","26747324","69424"],"Wikipedia":["Maltol"],"chEBI":["69438"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3181841","canonicalSmiles":"Cl.Cn1cc(C(=O)[C@@H]2CCc3[nH]cnc3C2)c2ccccc21","inchiKey":"XIXYTCLDXQRHJO-RFVHGSKJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAMOSETRON HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1643895","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(r)-(-)-ramosetron hydrochloride","Irribow","Ramosetron hydrochloride","YM-060","YM060","Ym060"],"crossReferences":{"PubChem":["144205994","170465928"]},"linkedTargets":{"rows":["ENSG00000149305","ENSG00000186090","ENSG00000178084","ENSG00000186038","ENSG00000166736"],"count":5},"linkedDiseases":{"rows":["EFO_0000555"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL323348","canonicalSmiles":"COC(=O)c1ccccc1C(=O)OC","inchiKey":"NIQCNGHVCWTJSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYL PHTHALATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avolin","Dimethyl o-phthalate","Dimethyl phthalate","Dimethylphtalate","Dimethylphthalate","Methyl phthalate","Mipax","NSC-15398","Palatinol m","Phthalic acid, dimethyl ester"],"crossReferences":{"PubChem":["144209343","144211362","17389503","225144196","26752743"],"Wikipedia":["Dimethyl_phthalate"],"drugbank":["DB13336"],"chEBI":["4609"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3237547","canonicalSmiles":"O=C1N[C@H](O)CCN1[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F","inchiKey":"VUDZSIYXZUYWSC-DBRKOABJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEDAZURIDINE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ASTX-727 COMPONENT CEDAZURIDINE","ASTX727 COMPONENT CEDAZURIDINE","Cedazuridine","E-7727","E7727"],"linkedTargets":{"rows":["ENSG00000158825"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616","EFO_0000339","EFO_0000756","EFO_0010832","EFO_0000222","EFO_0001663"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for myelodysplastic syndrome and has 2 investigational indications."}
{"id":"CHEMBL3264002","canonicalSmiles":"CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F","inchiKey":"LMMJFBMMJUMSJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CKI-27","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CKI-27","RG-7304","Ro-5126766"],"crossReferences":{"drugbank":["DB15254"],"chEBI":["78825"]},"childChemblIds":["CHEMBL3264004"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301589","drugType":"Antibody","blackBoxWarning":false,"name":"ENFORTUMAB VEDOTIN","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Padcev"],"synonyms":["AGS-22CE","AGS-22M6E","AGS-22ME","AGS-22MSE","ASG-22ME","Enfortumab vedotin","Enfortumab vedotin-ejfv"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000143217","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":10},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003863","MONDO_0003890","EFO_0008528","MONDO_0008315","MONDO_0020654","EFO_0000311","MONDO_0001187"],"count":8},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and is indicated for neoplasm and cancer and has 4 investigational indications."}
{"id":"CHEMBL3354350","canonicalSmiles":"CCCOC(=O)Cc1ccc(OCC(=O)N(CC)CC)c(OCC)c1","inchiKey":"QPUVKSKJCNGSGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-3043","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-3043","AZD3043","Azd 3043","Azd-3043","Azd3043","THRX-918661"],"crossReferences":{"drugbank":["DB12576"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL339427","canonicalSmiles":"COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C","inchiKey":"JFJZZMVDLULRGK-URLMMPGGSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"TUBOCURARINE","yearOfFirstApproval":1945,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["D-tubocurarine","Tubocurarine","Tubocurarine cation","Tubocurarine ion"],"crossReferences":{"PubChem":["26756599"],"drugbank":["DB01199"],"chEBI":["9774"]},"childChemblIds":["CHEMBL292280","CHEMBL3989821","CHEMBL1687"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1945."}
{"id":"CHEMBL34259","canonicalSmiles":"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1","inchiKey":"FBOZXECLQNJBKD-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHOTREXATE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amethopterin","Ebetrex","Emtexate high-pot","Emtexate pf","Folex","Maxtrex","Methotrexate","Metoject","Mexate","Otrexup","Otrexup pfs","Rasuvo","Reditrex","Rheumatrex","Trexall","Zlatal"],"synonyms":["(r)-methotrexate","ADX-2191","Abitrexate","Amethopterin","CL 14377","CL-14377","D-amethopterin","D-methotrexate","EMT-25299","Folex","Methotrexate","Methotrexate, (r)-","Methotrexate, d-","Methotrexatum","Methylaminopterin","Mexate","Mexate-AQ","NSC-740","R-9985","R-methotrexate","TCMDC-123832","TCMDC-125488","TCMDC-125858","Trexall"],"crossReferences":{"DailyMed":["methotrexate","methotrexate%20sodium"],"PubChem":["11113978","124886991","144204495","144210589","170464688","26752120","26752121","26752122","50104777","50104778","56463665","67627","90340825"],"Wikipedia":["Methotrexate"],"drugbank":["DB00563"],"chEBI":["44185"]},"childChemblIds":["CHEMBL4572304","CHEMBL3244648","CHEMBL1376974"],"linkedTargets":{"rows":["ENSG00000228716"],"count":1},"linkedDiseases":{"rows":["HP_0012410","EFO_0000637","EFO_0005952","EFO_1001129","EFO_1001951","EFO_0006803","EFO_1000318","EFO_1001935","EFO_0000588","EFO_0000096","EFO_0000339","EFO_0002690","EFO_1000956","MONDO_0002974","MONDO_0008903","Orphanet_3319","EFO_0008528","EFO_0000676","EFO_0004991","MONDO_0002038","Orphanet_42738","MONDO_0000159","EFO_0000198","MONDO_0013730","EFO_0000221","MONDO_0021054","EFO_1000811","EFO_0009012","MONDO_0019465","EFO_0001642","Orphanet_636","EFO_1001946","EFO_1000309","MONDO_0004986","EFO_0000384","EFO_0007187","EFO_1001231","EFO_1001365","EFO_0003032","EFO_0006818","MONDO_0019472","EFO_0004284","EFO_0000574","MONDO_0004979","EFO_0001378","Orphanet_231214","EFO_1000550","Orphanet_84","MONDO_0044903","MONDO_0007254","EFO_0000255","EFO_1001012","MONDO_0019541","EFO_1000298","MONDO_0003541","EFO_1001486","MONDO_0020654","EFO_0002430","EFO_0004289","EFO_0007208","EFO_0000183","EFO_0000707","Orphanet_447","MONDO_0003478","EFO_1000388","Orphanet_797","EFO_0000616","EFO_0006859","EFO_1001779","Orphanet_59305","MONDO_0019457","EFO_0001645","EFO_0003898","EFO_0000403","EFO_0000222","MONDO_0000870","EFO_0000319","EFO_0003929","HP_0031456","MONDO_0019469","EFO_0004599","EFO_0003843","EFO_1001471","EFO_0005297","EFO_0000764","EFO_1001947","MONDO_0002367","MONDO_0018906","EFO_0000557","Orphanet_2781","MONDO_0005178","EFO_0000729","MONDO_0000873","EFO_0003869","EFO_0001075","Orphanet_183660","EFO_0004274","EFO_1000131","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0004251","Orphanet_365","EFO_0000389","MONDO_0019460","MONDO_0019088","EFO_0000330","MONDO_0015540","EFO_1001176","EFO_0004208","EFO_1000789","EFO_0000094","EFO_1000785","EFO_0009441","EFO_0003802","EFO_1001857","EFO_0000220","EFO_0005856","MONDO_0008170","EFO_0009907","EFO_1001466","EFO_1000157","EFO_0005842","EFO_0000223","EFO_0002939","MONDO_0018848","MONDO_0044881","EFO_1000784","EFO_0000224","EFO_0002429","EFO_0003025","EFO_0009708","EFO_1001209","MONDO_0019474","EFO_1000986","Orphanet_811","MP_0001845","MONDO_0100096","EFO_0004192","EFO_0000398","EFO_0003851","MONDO_0044917","EFO_0002428","EFO_1001051","EFO_0006544","EFO_0000218","MONDO_0005090","MONDO_0003005","MONDO_0019471","EFO_1001494","EFO_0003812","Orphanet_232","MONDO_0004192","MONDO_0044887","EFO_0003778","EFO_1001945","MONDO_0002041","EFO_0000209","HP_0001915","EFO_1001469","EFO_0000274","EFO_0000305","MONDO_0001187","EFO_0002950","EFO_1001480","EFO_0005531","Orphanet_906","EFO_0000770","EFO_1001830","MONDO_0001657","MONDO_0020743","EFO_0010580","EFO_0000717","EFO_1000158","EFO_0000685","EFO_0000232","EFO_0000313","MONDO_0016717","EFO_0000621","EFO_0002609","EFO_0000311","EFO_0000211","EFO_0009784","MONDO_0005301","EFO_0000095","EFO_0006475","EFO_0001068","EFO_0005235","EFO_1001936","EFO_1002008","EFO_0000612","MONDO_0020077","MONDO_0024280","EFO_0000691","EFO_0000181","EFO_0003833","EFO_0002893","EFO_0003811","EFO_0003027"],"count":199},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 22 approved and 136 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3544992","drugType":"Antibody","blackBoxWarning":false,"name":"DENINTUZUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Denintuzumab","HBU-12","hBU12"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545101","drugType":"Small molecule","blackBoxWarning":false,"name":"KRP203","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Krp203"],"linkedTargets":{"rows":["ENSG00000170989"],"count":1},"linkedDiseases":{"rows":["EFO_0003834","EFO_0000729","EFO_0001642"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545164","canonicalSmiles":"C[C@@H](Oc1nnc(-c2ccncc2)n1C)c1cc(-c2cccc(Cl)c2)on1","inchiKey":"SXWHYTICXCLKDG-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD2066","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd 2066","Azd-2066","Azd2066"],"crossReferences":{"drugbank":["DB12644"]},"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_0003948","EFO_1000783","HP_0012532","MONDO_0002009","EFO_0003843"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3545317","drugType":"Antibody","blackBoxWarning":false,"name":"REFANEZUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK249320","Refanezumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545366","canonicalSmiles":"CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21","inchiKey":"RGHYDLZMTYDBDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOXTALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SAR-245409","SAR245409","Voxtalisib","XL-765","XL765"],"crossReferences":{"drugbank":["DB12400"]},"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000095","MONDO_0003268","EFO_0000756","MONDO_0008170","MONDO_0007254","EFO_0000574","EFO_1001469","EFO_0003060","EFO_0000519","EFO_0000311","EFO_1001951"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL3590187","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"GPNHMOZDMYNCPO-PDUMRIMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLASCOTERONE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Breezula","Winlevi"],"synonyms":["CB-03-01","Cb-03-01","Clascoterone","Cortexolone 17.alpha.-propionate","Cortodoxone 17.alpha.-propionate"],"crossReferences":{"drugbank":["DB12499"]},"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0003894","EFO_0004191"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 2 investigational indications."}
{"id":"CHEMBL3707220","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCCOC(CC)C(=O)O","inchiKey":"VOGXDRFFBBLZBT-AAQCHOMXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICOSABUTATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Icosabutate","NST-4016","PRB-01022","PRC-4016"],"crossReferences":{"drugbank":["DB12990"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3818875","canonicalSmiles":"CNc1nc(C)nc(N[C@H]2CCC[C@@H](C(=O)NCc3ccc(C#N)cc3C(F)(F)F)C2)n1","inchiKey":"LQHDJQIMETZMPH-ZBFHGGJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK2256294","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk2256294"],"linkedTargets":{"rows":["ENSG00000120915"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3833345","drugType":"Antibody","blackBoxWarning":false,"name":"BIRTAMIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Birtamimab","ELT1-01","Hu2A4","NEOD001"],"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3833374","drugType":"Antibody","blackBoxWarning":false,"name":"ANDECALIXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Andecaliximab","GS-5745","GS5745"],"linkedTargets":{"rows":["ENSG00000100985"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000685","EFO_0000503","Orphanet_586","EFO_0000341","EFO_0000384"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL389767","canonicalSmiles":"N#Cc1cnn2c(NCCc3cnc[nH]3)nc(Nc3ccccc3)nc12","inchiKey":"IWUUKHQIKFHWIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL389767","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08345"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL393820","canonicalSmiles":"CC(C)[C@H](N)C(=O)O[C@@H]1[C@@H](CO)O[C@@H](n2ccc(N)nc2=O)[C@]1(C)O","inchiKey":"TVRCRTJYMVTEFS-ICGCPXGVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALOPICITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NM-283","Valopicitabine"],"crossReferences":{"drugbank":["DB13920"]},"childChemblIds":["CHEMBL1743757"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 1 investigational indication."}
{"id":"CHEMBL3989558","canonicalSmiles":"CCC(CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1.O=C(O)/C=C\\C(=O)O","inchiKey":"LWYXFDXUMVEZKS-TZTNOGQLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYSERGIDE MALEATE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL485253","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sansert"],"synonyms":["Methysergide hydrogen maleate","Methysergide maleate","NSC-759143"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL3989691","canonicalSmiles":"CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\\Nc1cccc(-c2cccc(C(=O)O)c2)c1O.NCCO.NCCO","inchiKey":"PLILLUUXAVKBPY-SBIAVEDLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ELTROMBOPAG OLAMINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL461101","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Promacta","Promacta kit"],"synonyms":["Eltrombopag (as olamine)","Eltrombopag compd with 2-aminoethanol (1:2)","Eltrombopag olamine","SB-497115-GR"],"crossReferences":{"DailyMed":["eltrombopag%20olamine"]},"linkedTargets":{"rows":["ENSG00000117400"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0007160","EFO_0004220","EFO_0006927","HP_0001873"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 4 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989752","canonicalSmiles":"CN(C)CCC=C1c2ccccc2OCc2c1oc1ccccc21","inchiKey":"VZVRZTZPHOHSCK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXETORONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxetorone"],"crossReferences":{"drugbank":["DB13463"]},"childChemblIds":["CHEMBL3989638"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989769","drugType":"Small molecule","blackBoxWarning":true,"name":"NEOMYCIN SULFATE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Biomydrin","Biosol","Cicatrene","Cicatrin","Fradiomycin Sulfate","Gppe nsl gel","Graneodin","Mycifradin","Myciguent","Naseptin","Neo-fradin","Neo-rx","Neobacrin","Neobiotic","Neomycin sulfate","Neosporin","Nivemycin","Tribiotic","Vibrocil"],"synonyms":["Biosol","Bykomycin","Endomixin","Fradiomycin sulfate","Framycetin sulfate","Framycetin sulphate","Fraquinol","Myacine","NSC-757240","Neobrettin","Neomix","Neomycin b sulfate","Neomycin b sulphate","Neomycin b, sulfate (salt)","Neomycin b, sulphate (salt)","Neomycin sulfate","Neosulf","Soframycin","Tuttomycin"],"crossReferences":{"DailyMed":["neomycin%20sulfate"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and has 3 approved and 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989830","canonicalSmiles":"CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1.Cl.O","inchiKey":"KFNNPQDSPLWLCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIBUTRAMINE HYDROCHLORIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1419","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Canada"," China"," European Union"," Hong Kong"," India"," New Zealand"," United States"],"classes":["Cardiotoxicity"," Neurotoxicity"],"year":2010},"tradeNames":["Meridia"],"synonyms":["BTS 54524","BTS-54524","NSC-758928","Sibutramine hcl","Sibutramine hydrochloride","Sibutramine hydrochloride civ","Sibutramine hydrochloride hydrate","Sibutramine hydrochloride monohydrate"],"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and has 1 investigational indication. It was withdrawn in Canada,  China,  European Union,  Hong Kong,  India,  New Zealand and  United States initially in 2010 due to Cardiotoxicity and  Neurotoxicity."}
{"id":"CHEMBL3989996","drugType":"Antibody","blackBoxWarning":false,"name":"PORGAVIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zmapp"],"synonyms":["Porgaviximab","c2G4"],"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL400841","canonicalSmiles":"CN(C)C(=O)[C@@H]([C@H]1CC[C@H](c2cccc3ncnn32)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1","inchiKey":"ZPWDKZWKUOYOHA-UKSSEWCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL400841","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07135"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL415690","canonicalSmiles":"OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O","inchiKey":"WHGYBXFWUBPSRW-FOUAGVGXSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"BETADEX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".beta.-cyclodextrin","Beta cyclodextrin","Beta-cyclodextrin","Beta-schardinger dextrin","Betacd","Betadex","Cavamax w7","Cyclodextrin b","Cyclodextrin, beta-","Cycloheptaamylose","Cycloheptaglucan","Cyclomaltoheptaose","E-459","E459","INS NO.459","INS-459","Kleptose","NSC-269471","NSC-314334","Oristar bcd","Ringdex-b"],"crossReferences":{"PubChem":["144204568","144208204","170466376","17389955"],"drugbank":["DB03995"],"chEBI":["495055"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL415768","canonicalSmiles":"C=C1CC[C@H]2[C@@](C)(CC[C@@H](O)[C@@]2(C)CO)[C@@H]1CCC1=CCOC1=O","inchiKey":"GVRNTWSGBWPJGS-YSDSKTICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYANDROGRAPHOLIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["14-Deoxyandrographolide","Deoxyandrographolide"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL420","canonicalSmiles":"N=C(N)N/N=C/c1c(Cl)cccc1Cl","inchiKey":"WDZVGELJXXEGPV-YIXHJXPBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANABENZ","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Guanabenz","NSC-68982","WY-8678"],"crossReferences":{"PubChem":["26751943","50104618","50104619","90341577"],"Wikipedia":["Guanabenz"],"chEBI":["5553"]},"childChemblIds":["CHEMBL1200560"],"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["MONDO_0005301","EFO_0003929"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL4296717","canonicalSmiles":"CN(C)Cc1ccc(S(=O)(=O)n2ccc(/C=C/C(=O)NO)c2)cc1","inchiKey":"FECGNJPYVFEKOD-VMPITWQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESMINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4SC-201","4sc-201","BYK-408740","BYK408740","RAS-2410","RAS2410","Resminostat"],"crossReferences":{"drugbank":["DB12392"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297165","canonicalSmiles":"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.Cl.Cl","inchiKey":"PCFGECQRSMVKCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROQUINE HYDROCHLORIDE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL76","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aralen hydrochloride"],"synonyms":["Chloroquine hcl","Chloroquine hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1949 and has 2 investigational indications."}
{"id":"CHEMBL4297256","canonicalSmiles":"CC(C)(C(=O)NC1C2CC3CC1CC(C(N)=O)(C3)C2)N1CCN(c2ccc(C(F)(F)F)cn2)CC1","inchiKey":"CLHMYBJIOZXCEX-QIGVQZHLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-384","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abt-384"],"linkedTargets":{"rows":["ENSG00000117594"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297313","canonicalSmiles":"CC1(C)CC(OC(=O)C2CC2)CC(C)(C)N1O","inchiKey":"ZWEXEKJLDHNLLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OT-551","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ot-551"],"crossReferences":{"drugbank":["DB05650"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297426","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMARIUM SM-153","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4300244","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Samarium sm-153","Samarium-153","Sm-153"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297674","canonicalSmiles":"CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1","inchiKey":"VJPPLCNBDLZIFG-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRANEBRUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986195","Bms-986195","Branebrutinib"],"crossReferences":{"drugbank":["DB15347"]},"childChemblIds":["CHEMBL4639484"],"linkedTargets":{"rows":["ENSG00000010671"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000274"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297748","drugType":"Unknown","blackBoxWarning":false,"name":"EP-100","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EP-100","EP-100 (PEPTIDE)","Ep-100"],"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008170"],"count":2},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297879","drugType":"Protein","blackBoxWarning":false,"name":".ALPHA.1-PROTEINASE INHIBITOR HUMAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.-1 protease inhibitor",".alpha.1-antitrypsin",".alpha.1-proteinase inhibitor human","Alfa1 antitrypsin","Alpha 1-antitrypsin","Alpha-1 protease inhibitor","Alpha-1 proteinase inhibitor (human)","Alpha-1-antiproteinase","Alpha-1-antitrypsin","Alpha1-proteinase inhibitor","Alpha1-proteinase inhibitor (human)","Aralast","Atc-b02ab02","Glassia","Prolastin","Prolastin-c","Zemaira"],"linkedTargets":{"rows":["ENSG00000197561"],"count":1},"linkedDiseases":{"rows":["MONDO_0013730","MP_0001845","MONDO_0100096","Orphanet_60","EFO_0000464","MONDO_0005147","EFO_0008583","Orphanet_586","EFO_0000341","EFO_0000342","EFO_0000400"],"count":11},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL4297899","drugType":"Unknown","blackBoxWarning":false,"name":"AZD-0156","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD0156","Azd 0156","Azd-0156","Azd0156"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297957","drugType":"Small molecule","blackBoxWarning":false,"name":"AVASOPASEM MANGANESE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avasopasem manganese","Avasopasem manganese dichloride","GC-4419","GC4419","Gc4419","M-40419","SC-72325A"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4297993","drugType":"Unknown","blackBoxWarning":false,"name":"EMD-1201081","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emd-1201081","HYB-2055","IMO-2055","Imo-2055","Imoxine"],"linkedTargets":{"rows":["ENSG00000239732"],"count":1},"linkedDiseases":{"rows":["EFO_0000681","EFO_0003060","EFO_1001951"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297999","drugType":"Unknown","blackBoxWarning":false,"name":"ISIS-333611","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ISIS 333611","Isis 333611","Isis-333611"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4303060","canonicalSmiles":"CCOC(=O)[C@H](Cc1ccc(F)cc1)NC(=O)[C@@H](N)Cc1ccc(N(CCCl)CCCl)cc1","inchiKey":"YQZNKYXGZSVEHI-VXKWHMMOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MELPHALAN FLUFENAMIDE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["J 1 (PRODRUG)","J-1 (PRODRUG)","J1","Melflufen","Melphalan flufenamide","PRODRUG J 1","PRODRUG J-1"],"childChemblIds":["CHEMBL4297403"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2021 and is indicated for multiple myeloma and has 3 investigational indications."}
{"id":"CHEMBL4303611","canonicalSmiles":"O=C(/C=C/c1ccc2ccc(C(F)(F)F)cc2n1)c1ccncc1","inchiKey":"IAJOMYABKVAZCN-AATRIKPKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PFK-158","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pfk-158"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL431","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2","inchiKey":"HRWCVUIFMSZDJS-SZMVWBNQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPIRAPRIL","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Spirapril"],"crossReferences":{"Wikipedia":["Spirapril"],"drugbank":["DB01348"]},"childChemblIds":["CHEMBL1200831"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000319","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1994 and is indicated for cardiovascular disease."}
{"id":"CHEMBL431733","canonicalSmiles":"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@H](O)[C@@H]1O","inchiKey":"IPSYPUKKXMNCNQ-PFHKOEEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAMODENOSON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CF-102","CF102","CI-IB-MECA","CL-IB-MECA","Cf102","Chloro-ib-meca","Namodenoson"],"crossReferences":{"PubChem":["26752072","56463287"],"drugbank":["DB12885"]},"linkedTargets":{"rows":["ENSG00000282608"],"count":1},"linkedDiseases":{"rows":["EFO_0004220","EFO_0003095","EFO_0000182","EFO_1001249"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL44618","canonicalSmiles":"ClC(Cl)Cl","inchiKey":"HEDRZPFGACZZDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROFORM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Chloroform","Chloroform bp","Chloroformum","Hcc 20","NSC-77361","R 20 (refrigerant)"],"crossReferences":{"PubChem":["144209692","17389970"],"Wikipedia":["Chloroform"],"drugbank":["DB11387"],"chEBI":["35255"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL4594422","canonicalSmiles":"CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(NC)cc1OC","inchiKey":"NXKXZXNNWRYXRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LB-102","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LB-102","Lb-102","N'-methyl amisulpride","N'-methylamisulpride"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594481","drugType":"Unknown","blackBoxWarning":false,"name":"MEDI-547","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1c1-mcmmaf","Medi-547"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594575","drugType":"Antibody","blackBoxWarning":false,"name":"SABATOLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MBG-453","MBG453","Mbg 453","Mbg453","NVP-MBG453","Sabatolimab"],"linkedTargets":{"rows":["ENSG00000135077"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_1001779","MONDO_0044903","EFO_0000222","EFO_0000519","EFO_0000311"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL461522","canonicalSmiles":"Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C","inchiKey":"LVWZTYCIRDMTEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPYRONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Grecia"," Suecia"," Nepal"," Zimbabwe"," Yemen"],"classes":["Hematological toxicity"," Immune system toxicity"],"year":1975},"tradeNames":["Diprofarn","Novaldin"],"synonyms":["Dipyrone"],"crossReferences":{"drugbank":["DB04817"],"chEBI":["62088"]},"childChemblIds":["CHEMBL487894","CHEMBL3989803"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","HP_0100806","EFO_1001412","MONDO_0005277","EFO_1001463","HP_0012532","HP_0001945","EFO_0000712","HP_0003419","EFO_0003843","EFO_0003964"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for fever and pain and has 3 investigational indications. It was withdrawn in United Kingdom,  United States,  Grecia,  Suecia,  Nepal,  Zimbabwe and  Yemen initially in 1975 due to Hematological toxicity and  Immune system toxicity."}
{"id":"CHEMBL4650257","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"CEPADACURSEN SODIUM","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CIVI-007","CIVI007","Cepadacursen sodium"],"description":"Oligonucleotide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650377","drugType":"Unknown","blackBoxWarning":false,"name":"AV-380","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AV-380","Av-380","Av-380 (gdf15 mab)"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650423","drugType":"Unknown","blackBoxWarning":false,"name":"STI-3031","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IMC-001","Imc-001","STI-3031","Sti-3031"],"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650435","drugType":"Antibody","blackBoxWarning":false,"name":"BOTENSILIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGEN-1181","AGEN1181","Agen1181","Botensilimab"],"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802139","canonicalSmiles":"Cc1cc(OCP(=O)(O)O)cc(C)c1Cc1ccc(O)c(Cc2ccccc2)c1","inchiKey":"GFJCILQBXUTOGN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VK-0214","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VK-0214","VK0214","Vk-0214","Vk0214"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4802209","drugType":"Unknown","blackBoxWarning":false,"name":"INCB-086550","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["INCB-086550","INCB086550","Incb-086550","Incb086550"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL481931","canonicalSmiles":"CN1CC[C@H](N(C)C(=O)N2CC(c3cc(F)ccc3F)=C[C@@]2(CO)c2ccccc2)[C@H](F)C1","inchiKey":"MYBGWENAVMIGMM-GIFXNVAJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0731","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0731"],"crossReferences":{"drugbank":["DB08037"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489798","canonicalSmiles":"O=C1NC(=S)N[C@@]12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O","inchiKey":"OEWLGQKSTDZKFN-WWHASAIZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489798","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02964"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL495898","canonicalSmiles":"Oc1ccc(Cc2nnc3ccc(-c4ccccc4)nn23)cc1","inchiKey":"ZGJYGQLGSXWEMY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL495898","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08111"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL518043","canonicalSmiles":"Cc1cc(C(=O)N2CCCCc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=O)N(C)C","inchiKey":"RUOLFWZIFNQQGH-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEDOVAPAGON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fedovapagon","VA-106483"],"crossReferences":{"drugbank":["DB11734"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL52011","canonicalSmiles":"OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O","inchiKey":"SYKYBMOFPMXDRQ-ZFDCCPEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIODIGALACTOSIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thiodigalactoside"],"crossReferences":{"drugbank":["DB04396"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL538937","canonicalSmiles":"COCCOc1cc(C)nc(N)n1","inchiKey":"VCJHOFUOIQHNBC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL538937","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08786"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL538940","canonicalSmiles":"NCc1ccc(-c2cccs2)s1","inchiKey":"FHYTVXBZSXZMGD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL538940","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07094"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL571209","canonicalSmiles":"Cn1cc(C[C@@H](N)C(=O)O)c2ccccc21","inchiKey":"ZADWXFSZEAPBJS-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOXIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["1-methyltryptophan, d-","D-1-methyltryptophan","D-1MT","Indoximod","NLG-8189"],"crossReferences":{"PubChem":["536240"],"drugbank":["DB12827"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL574817","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H]1O","inchiKey":"WHTCPDAXWFLDIH-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL574817","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01812"],"chEBI":["17985"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL591501","canonicalSmiles":"CCCOCCn1c(=O)c(N2CCN(CCO)CC2)nc2cnc(-c3ccc(OC)nc3)cc21","inchiKey":"MNLNAGRCHNMKKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-03049423","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pf-03049423"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL599552","canonicalSmiles":"O=C1/C(=C2\\Nc3ccccc3C2=O)Nc2ccccc21","inchiKey":"COHYTHOBJLSHDF-BUHFOSPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIGO","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ao201","C.I.73000","Ci 73000","Indigo","Indigo blue","Indigo whole","Indigofera orthocarpa whole","Indigofera tinctoria","Indigofera tinctoria whole","Indigotin","NSC-8645","Nila whole","Nili whole","Nilika whole","Nilini whole","True indigo whole"],"crossReferences":{"PubChem":["144205605","144209743","170465746","26756710"],"Wikipedia":["Indigo_dye"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL706","canonicalSmiles":"CCCCCCCCCCCCCCCCO","inchiKey":"BXWNKGSJHAJOGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETYL ALCOHOL","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Alcohol cetylicus","C12-16 alcohols","Cetanol","Cetyl Alcohol","Cetyl alchol","Cetyl alcohol","FEMA NO. 2554","Fatty alcohols(c12-16)","Hexadecanol","N-1-hexadecanol","N-hexadecanol","NSC-4194","Palmitic alcohol"],"crossReferences":{"PubChem":["144205162","144210643","170465348","26754466","29215289","29215290"],"Wikipedia":["Cetyl_alcohol"],"drugbank":["DB09494"],"chEBI":["16125"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL807","canonicalSmiles":"CC12CC3CC(C)(C1)CC(N)(C3)C2","inchiKey":"BUGYDGFZZOZRHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEMANTINE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["D-145","DRG-0267","Memantine","NSC-757843","Namenda"],"crossReferences":{"DailyMed":["memantine%20hydrochloride"],"PubChem":["104171191","144203750","170464999","26751885","50104569","90341818"],"Wikipedia":["Memantine"],"drugbank":["DB01043"],"chEBI":["64312"]},"childChemblIds":["CHEMBL1882685","CHEMBL1699"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000161509","ENSG00000116032","ENSG00000273079","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0004190","EFO_0002610","EFO_0009386","MONDO_0002009","EFO_0011057","HP_0001268","EFO_0003768","EFO_0003757","HP_0012228","EFO_0020000","MONDO_0002046","HP_0100543","EFO_0002690","MONDO_0004681","MONDO_0004976","EFO_0005762","EFO_0003888","EFO_0003756","EFO_0005203","EFO_0003758","HP_0002381","Orphanet_399","EFO_1001488","EFO_0007328","EFO_0004699","EFO_0003108","MONDO_0005090","Orphanet_282","EFO_1001998","EFO_0005687","EFO_0004240","EFO_0003096","Orphanet_232","HP_0000726","EFO_1001465","EFO_0009267","MONDO_0005277","EFO_0000289","MONDO_0002050","EFO_1001801","MONDO_0005180","EFO_0000712","EFO_0000326","EFO_0001064","HP_0012167","EFO_0004242","MONDO_0007079","EFO_0005230","HP_0001337","HP_0002140","EFO_0004329","EFO_0005407","EFO_0001358","EFO_0001073","EFO_0003843","EFO_0001072","EFO_0003890","MONDO_0002491","MONDO_0005301","MONDO_0004975","EFO_0005611","MONDO_0043510","EFO_0003833","EFO_0005411","MONDO_0024880","EFO_0000519"],"count":66},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for alzheimer disease and dementia and has 49 investigational indications."}
{"id":"CHEMBL98350","canonicalSmiles":"O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12","inchiKey":"CZQHHVNHHHRRDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-294002","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-294002"],"crossReferences":{"PubChem":["103905473","11111398","11113937","124880604","124880606","124880607","26752090","26752091","525433","90341244"],"Wikipedia":["LY294002"],"drugbank":["DB02656"],"chEBI":["65329"]},"childChemblIds":["CHEMBL1398499"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
